Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

NF-κB as a primary regulator of the stress response

Oncogene volume 18, pages 6163–6171 (1999)Cite this article

Abstract

A myriad of unrelated exogenous or endogenous agents that represent a threat to the organism are capable of inducing NF-κB activity, including viral infection, bacterial lipids, DNA damage, oxidative stress and chemotherapuetic agents. Likewise, NF-κB regulates the expression of an equally diverse array of cellular genes. These findings are indicative of the widespread significance of NF-κB as a mediator of cellular stress. Remarkably, the NF-κB pathway displays the capacity to activate, in a cell- and stimulus-specific manner, only a subset of the total repertoire of NF-κB-responsive genes. The seemingly promiscuous nature of NF-κB activation poses a regulatory quagmire as to how specificity is achieved at the level of gene expression. The review will summarize recent findings and explore how they further our understanding of the mechanism by which stimulus-specific activation of NF-κB is achieved in response to cellular stress.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A and Ben-Neriah Y. . 1995 Proc. Natl. Acad. Sci. USA 92: 10599–10603.

  • Baeuerle PA and Baltimore D. . 1996 Cell 87: 13–20.

  • Baeuerle PA and Henkel T. . 1994 Annu. Rev. Immunol. 12: 141–179.

  • Baeuerle PA and Baichwal VR. . 1997 Adv. Immunol. 65: 111–136.

  • Baldwin Jr, AS. . 1999 Annu. Rev. Immunol. 14: 649–683.

  • Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dorken B. . 1997 J. Clin. Invest. 100: 2961–2969.

  • Belich MP, Salmeron A, Johnston LH and Ley SC. . 1999 Nature 397: 363–368.

  • Beg AA and Baltimore D. . 1996 Science 274: 782–784.

  • Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Harvard L, Merville MP and Bours V. . 1999 Mol. Cell. Biol. 3: 1950–1960.

  • Bours V, Dejardin E, Goujon-Letawe F, Merville MP and Castronovo V. . 1994 Biochem. Pharmacol. 47: 145–149.

  • Brown K, Gerstberger L, Carlson G, Franzoso G and Siebenlist U. . 1995 Science 267: 1485–1491.

  • Chen CC and Manning AM. . 1995 Agents Actions 47: 135–141.

  • Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D and Maniatis T. . 1995 Genes Dev. 9: 1586–1597.

  • Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH and Ballard DW. . 1997 Proc. Natl. Acad. Sci. USA 94: 10057–10062.

  • Ciechanover A. . 1998 EMBO J. 17: 7151–7160.

  • Delhase M, Hayakawa M, Chen Y and Karin M. . 1999 Science 284: 309–313.

  • DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M. . 1997 Nature 388: 853–862.

  • DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S and Karin M. . 1996 Mol. Cell. Biol. 16: 1295–1304.

  • Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ and Baldwin AS. . 1997 J. Biol. Chem. 272: 24113–24116.

  • Fisher DE. . 1994 Cell 78: 539–542.

  • Fuchs SY, Chen A, Xiong Y, Pan ZQ and Ronai Z. . 1999 Oncogene 18: 2039–2046.

  • Gilmore TD and Morin PJ. . 1993 Trends Genet. 9: 427–433.

  • Hammarskjold ML and Simurda MC. . 1992 J. Virol. 66: 6496–6501.

  • Harhaj EW and Sun SC. . 1999 J. Biol. Chem. 274: 22911–22914.

  • Hershko A and Ciechanover A. . 1992 Annu. Rev. Biochem. 61: 761–807.

  • Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA and Narayanan R. . 1993 Proc. Natl. Acad. Sci. USA 90: 9901–9905.

  • Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R and Karin M. . 1999 Science 284: 316–320.

  • Ishikawa H, Carrasco D, Claudio E, Ryseck RP and Bravo R. . 1997 F. Exp. Med. 186: 999–1014.

  • Jin DY, Giordano V, Nakano H and Jeang KT. . 1999 J. Biol. Chem. 274: 17402–17405.

  • Kaul N, Choi J and Forman HJ. . 1998 Free Radic. Biol. Med. 24: 202–207.

  • Lallena MJ, Diaz-Meco MT, Bren G, Paya CV and Moscat J. . 1999 Mol. Cell. Biol. 19: 2180–2188.

  • Latres E, Chiaur DS and Pagano M. . 1999 Oncogene 18: 849–855.

  • Lee FS, Hagler J, Chen ZJ and Maniatis T. . 1997 Cell 88: 213–222.

  • Li Q, Van Antwerp D, Mercurio F, Lee KF and Verma IM. . 1999a Science 284: 321–325.

  • Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC and Verma IM. . 1999b Genes Dev. 13: 1322–1328.

  • Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D and Horwitz MS. . 1999c Proc. Natl. Acad. Sci. 96: 1042–1047.

  • Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R and Karin M. . 1999d J. Exp. Med. 189: 1839–1845.

  • Malinin NL, Boldin MP, Kovalenko AV and Wallach D. . 1997 Nature 385: 540–544.

  • Matthew S, Murty, VV, Dalla-Favera R and Chaganti RS. . 1993 Oncogene 8: 191–193.

  • May MJ and Ghosh S. . 1998 Immunol. Today 19: 80–88.

  • Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin Jr, AS. . 1997 Science 278: 1812–1815.

  • Mercurio F, DiDonato JA, Rosette C and Karin M. . 1993 Gene Dev., 7: 705–718.

  • Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young D, Barbosa M, Mann M, Manning AM and Rao A. . 1997 Science 278: 860–866.

  • Mercurio F, Murray B, Bennett BL, Pascaul G, Shevchenko A, Zhu H, Young D, Li J, Mann M and Manning AM. . 1999 Mol. Cell. Biol. 19: 1526–1538.

  • Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H and Okumura K. . 1998 Proc. Natl. Acad. Sci. USA 95: 3537–3542.

  • Nakshatri H, Bhat-Nakshatri P, Martin D, Goulet R and Sledge G. . 1997 Mol. Cell. Biol. 17: 3629–3639.

  • Orian A, Whiteside S, Israel A, Stancovski I, Schwartz AL and Ciechanover A. . 1995 J. Biol. Chem. 270: 21707–21714.

  • Rice NR, MacKichan ML and Israel A. . 1992 Cell 71: 243–253.

  • Rothwarf DM, Zandi E, Natoli G and Karin M. . 1998 Nature 395: 297–300.

  • Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT and Moscat J. . 1999 EMBO J. 18: 3044–3053.

  • Shi X, Dong Z, Huang C, Ma W, Liu K, Ye J, Chen F, Leonard SS, Ding M, Castranova V and Vallyathan V. . 1999 Mol. Cell Biochem. 194: 63–70.

  • Sokoloski JA, Sartorelli AC, Rosen CA and Narayanan R. . 1993 Blood 82: 625–632.

  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM and Sonenshein GE. . 1997 J. Clin. Invest. 100: 2952–2960.

  • Tan P, Fuchs SY, Chen A, Wu K, Gomez C and Ronai Z. . 1999 Mol. Cell 4: 527–533.

  • Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. . 1996 Science 274: 787–789.

  • Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M and Fusco A. . 1997 Oncogene 15: 1987–1994.

  • Wang C, Mayo M and Baldwin AS. . 1996 Science 274: 784–787.

  • Wang C-Y, Mayo MW, Korneluk RG, Goeddell DV and Baldwin AS. . Science 281: 1680–1683.

  • Wang D and Baldwin Jr, AS. . 1998 J. Biol. Chem. 45: 29411–29416.

  • Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF. . 1998 Science 281: 998–1001.

  • Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israël A. . 1998 Cell 93: 1231–1240.

  • Yaron A, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Gonen H, Ciechanover A and Ben-Neriah Y. . 1997 EMBO J. 16: 101–107.

  • Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F and Ben-Neriah Y. . 1998 Nature 396: 590–594.

  • Yin M-Y, Christerson LB, Yamamoto Y, Kwak Y-T, Xu S, Mercurio F, Barbosa M, Cobb MH and Gaynor RB. . 1998 Cell 93: 875–884.

  • Zandi E, Rothwarf DM, Delhasse M, Hayakawa M and Karin M. . 1997 Cell 91: 243–252.

  • Zhao Q and Lee FS. . 1999 J. Biol. Chem. 274: 8355–8358.

  • Zhong H, Yang HS, Erdjument-Bromage H, Tempst P and Ghosh S. . 1997 Cell 89: 413–424.

  • Zhong H, Voll RE and Ghosh S. . 1998 Molec. Cell 1: 661–671.

Download references

Author information

Authors and Affiliations

  1. Signal Pharmaceuticals, Inc., 5555 Oberlin Drive, San Diego, 92121, California, CA, USA

    Frank Mercurio & Anthony M Manning

Authors
  1. Frank Mercurio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony M Manning
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercurio, F., Manning, A. NF-κB as a primary regulator of the stress response. Oncogene 18, 6163–6171 (1999). https://doi.org/10.1038/sj.onc.1203174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203174

Keywords

This article is cited by

Search

Advanced search

Quick links